Product Images Mitomycin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Mitomycin NDC 65219-564 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Mitomycin-Spl-Structure - mit07 0000 01

Mitomycin-Spl-Structure - mit07 0000 01

Fresenius Kabi Logo - mit07 0000 02

Fresenius Kabi Logo - mit07 0000 02

Principal Display Panel – Mitomycin for Injection, USP 5 mg/vial – Carton - mit07 0000 03

Principal Display Panel – Mitomycin for Injection, USP 5 mg/vial – Carton - mit07 0000 03

This is a medication called Mitomycin, which is a Cytotoxic Agent used in the treatment of cancer. It comes in a single-dose vial and should be administered intravenously to avoid tissue damage. The product should be stored in the carton and kept protected from light at a temperature between 15°C and 30°C. It should be dissolved by adding 10mL of Sterile Water for Injection, USP and shaking it. Each mL solution contains 0.5 mg Mitomycin. The reconstituted solution should be discarded after 7 days. The usual posology is not available, therefore, prescribing information should be referred to. Manufactured for Fresenius Kabi in India.*

Principal Display Panel – Mitomycin for Injection, USP 5 mg/vial – Vial Label - mit07 0000 04

Principal Display Panel – Mitomycin for Injection, USP 5 mg/vial – Vial Label - mit07 0000 04

Principal Display Panel – Mitomycin for Injection, USP 20 mg/vial – Carton - mit07 0000 05

Principal Display Panel – Mitomycin for Injection, USP 20 mg/vial – Carton - mit07 0000 05

This is a product description of a Mitomycin injection manufactured in India. It contains 0.5mg of Mitomycin. It is packaged in a 40 mg vial and should be mixed with 40mL sterilised water. One needs to shake the product before consuming it. The reconstituted solution should be stored between 5°C and 0°C. The product needs to be administered intravenously and avoided excessive heat. For more details, one can refer to the package insert for full prescribing.*

Principal Display Panel – Mitomycin for Injection, USP 20 mg/vial – Vial Label - mit07 0000 06

Principal Display Panel – Mitomycin for Injection, USP 20 mg/vial – Vial Label - mit07 0000 06

The text is a product label for Mitomycin, a medication that is intended for intravenous administration. It comes in a single-dose vial containing 20mg of Mitomycin and 40mg of mannitol. The vial needs to be dissolved in 40mL of sterile water for injection USP. The usual dosage is not mentioned. Storage instructions include storing the container dry powder at 25°C and reconstituted solution under refrigeration 2° to 8°C, avoiding excessive heat and light. In case unrefrigerated, discard after 7 days. *

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.